Works cited by this work

125 works

Work: CAR‐NK Cell Biology and Engineering for Solid Tumors, With a Focus on Lung Cancer

1. Disorders of cancer metabolism: The therapeutic potential of cannabinoids

   Dingya Sun, Xin Li, Shengdan Nie +2

   Review article20229 citations

   ABIABI:AkademIndex/openalex/2026.other.153320

2. Metal organic framework coated MnO2 nanosheets delivering doxorubicin and self-activated DNAzyme for chemo-gene combinatorial treatment of cancer

   Yunbo Nie, Dan Li, Ying Peng +5

   Article20209 citations

   ABIABI:AkademIndex/openalex/2026.other.320084

3. The Benefits and Safety of Monoclonal Antibodies: Implications for Cancer Immunotherapy

   Shuguang Zhang, Wen‐Ying Chen, Jihong Zhou +5

   Review article20257 citations

   ABIABI:AkademIndex/openalex/2026.other.340938

4. Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies

   Ding-Ya Sun, Yijie Hu, Xin Li +3

   Review article20247 citations

   ABIABI:AkademIndex/openalex/2026.other.462660

5. Anticancer Activity and Mechanism of Xanthohumol: A Prenylated Flavonoid From Hops (Humulus lupulus L.)

   Chuanhao Jiang, Taoli Sun, Daxiong Xiang +2

   Review article20186 citations

   ABIABI:AkademIndex/openalex/2026.other.249498

6. Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

   Enli Liu, David Marín, Pinaki P. Banerjee +24

   Article20206 citations

   ABIABI:AkademIndex/openalex/2026.other.312682

7. A <scp>TGF</scp>‐β signaling‐related <scp>lncRNA</scp> signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response

   Weiwei Duan, Liting Yang, Jian Liu +13

   Article20236 citations

   ABIABI:AkademIndex/openalex/2026.other.316100

8. Platinum–Iron Nanoparticles for Oxygen-Enhanced Sonodynamic Tumor Cell Suppression

   Qianya Dong, Zhenqi Jiang

   Article20245 citations

   ABIABI:AkademIndex/openalex/2026.other.112366

9. <i>In vivo</i> kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection

   Yan Zhang, Diana L. Wallace, Catherine M. de Lara +8

   Article20073 citations

   ABIABI:AkademIndex/openalex/2026.other.296798

10. CAR-NK cells: A promising cellular immunotherapy for cancer

    Guozhu Xie, Han Dong, Yong Liang +3

    Review article20203 citations

    ABIABI:AkademIndex/openalex/2026.other.296868

11. Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy

    Ying Gong, Roel G. J. Klein Wolterink, Jianxiang Wang +2

    Review article20213 citations

    ABIABI:AkademIndex/openalex/2026.other.296881

12. Roles of IFN-γ in tumor progression and regression: a review

    Dragica Jorgovanović, Mengjia Song, Liping Wang +1

    Review article20203 citations

    ABIABI:AkademIndex/openalex/2026.other.816527

13. Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy

    Antonio Di Stasi, Siok‐Keen Tey, Gianpietro Dotti +17

    Article20112 citations

    ABIABI:AkademIndex/openalex/2026.other.082773

14. Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity

    Congcong Zhang, Pranav Oberoi, Sarah Oelsner +4

    Article20172 citations

    ABIABI:AkademIndex/openalex/2026.other.095598

15. Transforming Growth Factor-β Signaling in Immunity and Cancer

    Eduard Batlle, Joan Massagué

    Review article20192 citations

    ABIABI:AkademIndex/openalex/2026.other.095614

16. Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

    Leena Gandhi, Delvys Rodríguez‐Abreu, Shirish M. Gadgeel +26

    Article20182 citations

    ABIABI:AkademIndex/openalex/2026.other.097054

17. The inducible caspase-9 suicide gene system as a “safety switch†to limit on-target, off-tumor toxicities of chimeric antigen receptor T cells

    Tessa Gargett, Michael P. Brown

    Review article20142 citations

    ABIABI:AkademIndex/openalex/2026.other.102821

18. Tracking the Evolution of Non–Small-Cell Lung Cancer

    Mariam Jamal‐Hanjani, Gareth A. Wilson, Nicholas McGranahan +80

    Article20172 citations

    ABIABI:AkademIndex/openalex/2026.other.102844

19. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

    Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson +15

    Article20162 citations

    ABIABI:AkademIndex/openalex/2026.other.170118

20. Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways

    Yan Yang, Saiaditya Badeti, Hsiang-chi Tseng +5

    Article20202 citations

    ABIABI:AkademIndex/openalex/2026.other.431561

21. Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules

    Stephanie Slania, Deepankar Das, Ala Lisok +7

    Article20212 citations

    ABIABI:AkademIndex/openalex/2026.other.466629

22. Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

    Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella +11

    Article20042 citations

    ABIABI:AkademIndex/openalex/2026.other.592604

23. Human CD56bright NK Cells: An Update

    Tatiana Michel, Aurélie Poli, Angélica Cuapio +4

    Review article20162 citations

    ABIABI:AkademIndex/openalex/2026.other.598517

24. Comprehensive genomic characterization of squamous cell lung cancers

    Gad Getz, Stephen E. Schumacher, Petar Stojanov +97

    Article20122 citations

    ABIABI:AkademIndex/openalex/2026.other.616390

25. Natural killer cells infiltrating human nonsmall‐cell lung cancer are enriched in CD56^brightCD16⁻ cells and display an impaired capability to kill tumor cells

    Paolo Carrega, Barbara Morandi, Roberta Costa +7

    Article20082 citations

    ABIABI:AkademIndex/openalex/2026.other.827477